Latest Drug Safety news
FDA Panel Backs Two Peptides For Compounding, Rejects One
posted July 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Advisers Dismiss Safety Warnings, Back Four Peptide Treatments
posted July 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASH: No Specific Harms Found for Hydroxyurea Use During Pregnancy
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring 
Vitamin C Supplements in Pregnancy May Boost Infant Emotional Well-Being 
Excessive Gestational Weight Gain Linked to Severe Maternal Morbidity 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment Related Articles
Unintentional Ingestion of Recreational Drugs Increased, Especially Since 2013 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Real-World ARIA Incidence With Lecanemab Aligns With Clinical Trial Findings 
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs Monthly Specialist Briefings
Stay Connected
